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selected based on previous literature, 11, [13] [14] [15] [25] [26] [27] [28] biologic plausibility, and/or consensus opinion of the investigators based on their clinical experience. Candidate risk factors were not meant to be exhaustive; to minimize potential type 1 error, patient factors were limited to sociodemographic factors and factors that could alter the perceived risk-to-benefit ratio of initiating EGDT (eg, less severely ill patients may not have EGDT initiated). Acute Physiology and Chronic Health Evaluation (APACHE) II score was calculated based on initial variables obtained in the ED. 27 Consistent with the APACHE methods, 27 organ dysfunction was categorized as absent if unmeasured. Our assessment of clinician factors was limited to the attending physician. 28 Using a predrafted case report form, three trained investigators recorded the relevant patient, clinician, and organizational data from the EMR. ED therapies, including EGDT interventions and resuscitation end points (eg, Scv o 2 ), were also recorded, as was mortality. Each case was assessed by a second investigator for completeness and accuracy.
Outcomes
The primary outcome was the noninitiation of EGDT. EGDT initiation was defi ned as the measurement of Scv o 2 via CVC in the ED. Scv o 2 was the resuscitation end point that distinguished the EGDT group in the trial by Rivers et al 2 and its measurement has been used to defi ne EGDT initiation previously. 20 EGDT was categorized as initiated in 13 patients in whom Scv o 2 was measured via preexisting CVC (eg, peripherally inserted central catheter). The secondary outcome was EGDT completion. EGDT was completed if the following targets were achieved in the ED: CVP Ն 8 mm Hg, MAP Ն 65 mm Hg, and Scv o 2 Ն 70%. 2, 9, 20 
Statistical Analysis
Comparisons between patients in whom EGDT was and was not initiated were tested using the Student t test or Wilcoxon rank-sum test for continuous variables or the x 2 statistic or Fisher exact test for categorical variables. We used the nonparametric test for trends across ordered groups and the Mantel-Haenszel statistic for stratifi ed analyses.
Multivariable logistic regression was used to adjust for potential confounding and the results are presented as adjusted odds ratios (OR) with 95% CI. Separate models were created for patient and organizational factors. Candidate risk factors for the noninitiation of EGDT were included in the models if the P value was , .20 in univariate analyses. Potential confounders, including attending information, were added one at a time to the model and maintained if the point estimate for the OR of any of the candidate risk factors was altered by . 10%. 29 Nonnormally distributed continuous variables were categorized. Multicollinearity, assessed using variance infl ation factors, 30 was detected between APACHE II score and age, MAP, and hematocrit; these variables were not included in the model separately. Finally, patient, clinician, and organizational risk factors found to be signifi cantly associated with the noninitiation of EGDT at the Յ 0.05 level were included in a model simultaneously. Statistical signifi cance was defi ned as a P value of Յ 0.05. Analyses were conducted using Stata 10.1 software (Stata Datacorp; College Station, TX).
Results

Baseline Characteristics
The EGDT-eligible cohort included 340 adults ( Fig 1 ) . The age range of the cohort was 18 to 101 years and 54% were men. Septic shock was the criterion validated the effectiveness of protocol-directed resuscitation 3-8 and its use has been advocated in practice-based guidelines for sepsis management. 9 The failure to translate evidence into practice has been identifi ed as one of the great challenges of modern medicine. 10 Despite advances in the care of critically ill patients, evidence-based interventions remain underused. [11] [12] [13] [14] [15] To date, few institutions have adopted a formal protocol for the delivery of EGDT. [16] [17] [18] [19] In institutions that have adopted protocol-based resuscitation, compliance ranges from 50% to 60%. 20, 21 Despite evidence that the introduction of an EGDT protocol at our institution was associated with lower mortality compared with historical controls, 4 we recently reported that EGDT was underused in patients with severe sepsis and septic shock at our institution for unclear reasons. 22 Because mortality exceeded 35% in these patients, it is important to understand why a potentially life-saving intervention like EGDT was not implemented. 22 Why EGDT is underused in centers that have adopted an EGDT protocol has not been studied. The primary goal of this study was to identify potential barriers to the implementation of EGDT in the ED. We hypothesized that patient, clinician, and organizational factors would be associated with the noninitiation of EGDT.
Materials and Methods
The Institutional Review Board of the University of Pennsylvania approved the study with an informed consent waiver. This was a retrospective cohort study of EGDT-eligible patients admitted through the University of Pennsylvania ED between 2005 and 2007. In late 2004, our ED institutionalized a Severe Sepsis protocol to identify and treat all EGDT-eligible patients. EGDT eligibility was defi ned as a serum lactate Ն 4 mmol/L in hemodynamically stable patients (occult shock) or systolic BP , 90 mm Hg after volume resuscitation (1,500 mL). [2] [3] [4] [5] 8, 20, 23, 24 A Severe Sepsis Consultation Service was available to facilitate the effective implementation of EGDT. The Sepsis Service was staffed by one of two attending ED physicians continuously.
EGDT-eligible patients were identifi ed within our ED severe sepsis cohort. 22 Admitted patients were screened for inclusion if serum lactate was measured in the ED or a physician documented any of the following in the ED electronic medical record (EMR): sepsis, severe sepsis, cryptic septic shock, septic shock, or EGDT. The EMR of these patients was then evaluated for evidence of severe sepsis in the ED. Sepsis, severe sepsis, and septic shock were defi ned according to the International Sepsis Defi nitions Conference criteria. 23, 24 Subjects were excluded if criteria for severe sepsis were not met, if serum lactate was not measured ( , 2% of exclusions), or if the placement of a central venous catheter (CVC) was refused by the patient or their proxy (n 5 15). Subjects with a do-not-resuscitate order were not excluded. The details of our ED severe sepsis cohort have been previously published. 22 
Data Collection and Exposures
Candidate risk factors hypothesized to be associated with the noninitiation of EGDT were categorized into patient, clinician, and organizational factors ( Table 1 ) . Candidate risk factors were cians who were female ( P 5 .017) and in practice for more years ( P 5 .026). The use of the Sepsis Service also differed signifi cantly by attending, ranging from 0% to 100%. The Sepsis Service was less likely to be activated by physicians who were women ( P 5 .017), older ( P 5 .028) and in practice for more years ( P 5 .002).
We identifi ed nine patient-specifi c factors that were associated with the noninitiation of EGDT in unadjusted analyses ( Table 4 ) . EGDT was less likely to be initiated in women ( P 5 .001). This association was independent of the sex of the physician; female subjects were less likely to have EGDT initiated whether the attending was a woman (OR 5 0.29; 95% CI: 0.13, 0.65) or a man (OR 5 0.54; 95% CI: 0.32, 0.92; P , .001). EGDT initiation was less likely in patients who were younger ( P 5 .043) and less severely ill, as measured by higher initial MAP ( P 5 .002), lower lactate levels ( P 5 .014), lower APACHE II scores ( P 5 .001), and less coagulation dysfunction. Finally, patients with a preexisting CVC ( P 5 .013) and patients with bacteremia as the cause of sepsis ( P 5 .02) were less likely to have EGDT initiated.
We identifi ed three organizational factors that were associated with the noninitiation of EGDT in unadjusted analyses ( Table 5 ). First, EGDT was less likely to be initiated when the Sepsis Service was not consulted ( P , .001). Second, EGDT was less likely to be initiated in occult shock patients, compared with patients fulfi lling the hemodynamic criterion (50% vs 65%, P 5 .006). Follow-up lactate levels for EGDT in 183 patients (54%); 157 (46%) fulfi lled occult shock criteria.
EGDT was not initiated in 142 patients (42%). The EGDT group (n 5 198) received more IV fl uids ( P , .001), vasoactive agents ( P , .001), and central venous catheterizations ( P , .001) ( Table 2 ). The inhospital mortality rate was 33% in the EGDTinitiated group and 30% in the EGDT noninitiated group ( P 5 .52). The odds of inhospital death, adjusted for each patient, clinician, and organizational factor found to be associated independently with the noninitiation of EGDT in separate multivariable models, was not signifi cantly different in the EGDT-initiated group (adjusted OR 5 0.95; 95% CI: 0.52, 1.75; P 5 .87).
EGDT was not completed in 86 of 198 (43%) patients in whom EGDT was initiated. The inhospital mortality rate was 36% in the 86 patients in whom EGDT was initiated but not completed, compared with 30% in those in whom EGDT was completed ( P 5 .40). The CVP target was not achieved in 43 patients, the MAP target was not achieved in 18 patients, and the ScvO 2 target was not achieved in 44 patients. EGDT was completed in 33% of the overall cohort. The rate of EGDT completion signifi cantly decreased over the 2-year observational period ( P 5 .003); by 6-month interval, rate of completion decreased from 48% to 35% to 25% to 22%.
The patients were managed by 33 physicians ( Table 3 ) . Compliance with EGDT (initiation and completion) varied signifi cantly by attending, ranging from 0% to 100%. EGDT was less likely to be initiated by physi- a EGDT initiation would be less likely in patients fulfi lling the serum lactate rather than the hemodynamic criterion; as such, eligibility criteria could affect protocol implementation. Serum lactate and hemodynamic data were analyzed in the patient factor model. b The initiation of EGDT may be infl uenced by the service admitting the septic patient, as nonmedical services can assume primary care for the patient in the ED. All patients admitted to nonmedical services (surgery, obstetrics and gynecology, neurology, and neurosurgery) fulfi lled criteria for sepsis and EGDT in the ED. c EGDT initiation would be less likely in patients with certain comorbidities (congestive heart failure, end-stage renal disease, or chronic liver failure) and characteristics (ie, increased bleeding risk secondary to coagulopathy, thrombocytopenia). d Occupancy, the percentage of ED beds fi lled at the time of patient triage, was used to measure ED crowding. 25 Figure 1. Patients meeting criteria for EGDT, EGDT compliance, and severity of illness measures and outcomes by subgroup. The primary comparison was between the EGDT-initiated and noninitiated subgroups. APACHE 5 Acute Physiology and Chronic Health Evaluation; EGDT 5 early goal-directed therapy.
APACHE II score and the presence of coagulation dysfunction, was not associated independently with EGDT initiation in the complete model, nor was admission to a nonmedical service ( Table 6 ) .
Discussion
In this single-center cohort study, we found that EGDT was not initiated in 42% of eligible patients and was incomplete in 43% of patients in whom EGDT was initiated. We identifi ed potential barriers to the initiation of EGDT at the patient, clinician, and organizational level. At the patient level, sex and severity of illness appeared to infl uence the decision to initiate EGDT. We found that the rate of EGDT use varied widely at the physician level and the sex of the physician appeared to infl uence whether EGDT was initiated; at the organizational level, we found that when the Severe Sepsis Service was not activated, EGDT was signifi cantly less likely to be initiated and less likely to be completed in those in whom EGDT was initiated.
Our fi ndings demonstrate the challenges that exist in translating evidence into clinical practice effectively. Despite evidence that adoption of EGDT led to improved outcomes at our institution, 4 EGDT was underused. Even when EGDT was initiated, CVP and ScvO 2 targets were not achieved in . 20% of cases. Prior studies 2-8, [31] [32] [33] [34] [35] suggest that the observed mortality in the cohort would have been lower had EGDT been implemented effectively and these benefi ts appear to last beyond the initial hospitalization. 36 Despite significantly higher APACHE II scores in the EGDT-initiated group, their observed mortality was comparable to the EGDT non-initiated group, suggesting both a benefi t were decreasing in 98% (60/61) of the occult shock patients who did not receive EGDT; levels remained Ն 4 mmol/L in 25% (15/61) of cases. Finally, EGDT was less likely to be initiated in patients admitted to nonmedical services ( P 5 .049). The rate of EGDT initiation did not signifi cantly decline over the 2-year period of observation ( P 5 .22); by 6-month interval, use was 61%, 60%, 59%, and 51%. The use of the Sepsis Service declined over the 2-year interval ( P 5 .005); use decreased from 61% to 48% to 40% in the last two epochs. The association between consultation to the Sepsis Service and EGDT initiation was observed within each 6-month interval ( P , .001 in each epoch). In patients in whom EGDT was initiated, EGDT was less likely to be completed when the Sepsis Service was not consulted (44% vs 62%, P 5 .02).
Independent patient-specifi c risk factors associated with decreased odds of initiating EGDT included: female sex ( P 5 .002), lower severity of illness, as measured by the ED APACHE II score ( P 5 .013), and the absence of coagulopathy ( P 5 .007) ( Table 6 ). Organizational factors associated with the noninitiation of EGDT included: serum lactate (rather than hemodynamic) criterion for EGDT eligibility ( P 5 .024), admission to a nonmedical service ( P 5 .021), and failure to consult the Sepsis Service ( P , .001). The six risk factors identifi ed remained statistically signifi cant when attending demographics were included in each model.
When patient, clinician, and organizational risk factors were included simultaneously in a separate multivariable logistic regression model, four risk factors were found to be associated independently with decreased odds of initiating EGDT: female sex of the patient ( P 5 .001), female sex of the clinician ( P 5 .041), lactate (rather than hemodynamic) criterion for EGDT ( P 5 .018), and failure to consult the Sepsis Service ( P , .001). Severity of illness, as measured by higher would be reasonable to focus future efforts on achieving goal Scv o 2 to improve outcomes. Our observed compliance rates are consistent with those reported previously. [19] [20] [21] Nguyen and colleagues 20 reported 51% compliance with EGDT initiation at the inception of their EGDT protocol, which increased to 83% after 2 years; similarly, the rate of EGDT completion increased from 8% to 54%. More recently, Ferrer et al 35 reported that despite a nationwide education effort to improve compliance with processes of care for patients with severe sepsis, EGDT was initiated in , 40% of eligible patients and , 10% had EGDT completed.
We did not observe an increase in the rate of EGDT initiation at our institution; however, we did observe a signifi cant decline in the rate of EGDT completion. Importantly, we did not use a formal feedback mechanism to providers as others have implemented successfully. 20, 38 In lieu of a formal feedback mechanism, we developed a consultation service to facilitate the implementation of EGDT. The use of the consultation service was strongly associated with EGDT initiation and EGDT completion; however, the service was underused at the inception of the protocol and its use decreased over time, a fi nding that may explain the decline in EGDT completion rate. Potential reasons that the service was used less over time include physician fatigue with the service, physician dissatisfaction with the services provided, and the perception that consultation, over time, was no longer necessary to implement the protocol effectively. Furthermore, the use of the service, and EGDT itself, varied significantly at the practitioner level, which serves to highlight the fact that some physicians will adopt protocols more readily, whereas the inertia of previous practice for initiating and completing EGDT in patients who are more severely ill and potential harm when EGDT is not initiated or not completed. Given recent evidence that failure to achieve target Scv o 2 within the fi rst 6 h is associated with increased mortality, 37 it less likely to initiate EGDT. Our fi nding that sex-based differences exist in the delivery of protocol-based resuscitation warrants further investigation. Finally, patients experiencing occult shock were less likely to have EGDT initiated than patients fulfi lling the hemodynamic EGDT criterion. Occult shock accounted for 46% of eligible patients; EGDT was not initiated in 50% of these patients. Although follow-up lactate measurements were decreasing in 98% of these patients, 25% remained eligible for EGDT and yet EGDT was still not initiated. Previous research suggests that patients with occult shock may derive an even greater mortality benefi t from EGDT, 42 yet serum lactate measurements remain underused. 19 Within our observational study, it is impossible to determine how outcomes were affected by the failure may prove to be a barrier to protocol adherence for others. 11 We are directing our current efforts to understand provider-specifi c reasons for not using the consultation service, as the service appears to be an effective strategy to improve protocol adherence.
We identifi ed several potential barriers to the effective implementation of EGDT, in addition to nonconsultation to the Sepsis Service. First, sex appears to infl uence the decision of whether to initiate EGDT. EGDT was less likely to be initiated in women. Sex-based differences in care have been observed in cardiovascular medicine 26 and, more recently, in critical care medicine. 39, 40 Females are less likely to be admitted to an ICU and to receive invasive procedures and these fi ndings may adversely affect outcomes. 39, 40 Sex-based disparities may refl ect differences in patient preferences or they may refl ect preferences perceived by the patient's proxy or physician. 40 Alternatively, as seen in the critically ill elderly patient, 41 physicians may underestimate female patients' desire for aggressive care and, as a result, may withhold EGDT. Interestingly, we found that the sex of the physician may also infl uence EGDT use, as female physicians were effective implementation of EGDT. We found that a consultation service to facilitate the implementation of EGDT may be an effective strategy to improve protocol adherence. Whether EGDT underuse is due to underrecognition, disagreement with its use for specifi c patients, organizational barriers, or a combination thereof, is unknown and requires further investigation.
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Author contributions: Dr Mikkelsen: contributed to study conception and design, data collection, analysis and interpretation of the data, drafting of the manuscript, and critical revision of the article for important intellectual content. Dr Gaieski: contributed to study conception and design, data collection, analysis and interpretation of the data, drafting of the manuscript, and critical revision of the article for important intellectual content. Dr Goyal: contributed to study conception and design, data collection, analysis and interpretation of the data, and drafting of the manuscript. to initiate and/or complete EGDT and it is unclear why EGDT was less likely to be initiated in occult shock patients. Admittedly, this observation may refl ect how patient-specifi c disease severity infl uences the use of EGDT. Regardless, the potential impact of underusing EGDT in patients with occult shock warrants further investigation. It is unclear how the factors we identifi ed infl uenced the decision of whether to initiate EGDT. EGDT may not have been initiated because of barriers related to physician knowledge or attitudes regarding EGDT. 11 For example, it is possible that physicians failed to recognize that patients were eligible for EGDT (eg, less ill, occult shock). Alternatively, physicians may have decided to implement EGDT in the most severely ill patients only, or to modify or not use EGDT in others based on objective data or inherent biases. As is the case for translating evidence into practice in general, [14] [15] [16] [17] 26 disease severity likely affects the timely recognition of eligible patients as well as the decision to apply EGDT to a given patient.
There are several important limitations to our study. First, we acknowledge that relevant information pertaining to the complex decision to use EGDT may not have been identifi ed, and a cause-and-effect relationship cannot be determined, through our observational study design. Furthermore, we are unable to comment on other important processes of care (eg, early and appropriate antibiotics) that affect the outcomes of septic patients. We are also unable to determine how outcomes were affected by underusing EGDT; confounding by indication impairs our ability to compare the observed mortality between the EGDT-initiated and EGDT noninitiated groups. Second, our study is subject to type 1 error given the multiple comparisons used. Although we adjusted for potential confounding and limited our hypotheses, our fi ndings are hypothesis-generating and warrant confi rmation. Third, we acknowledge the potential for misclassifi cation bias based on our defi nition of EGDT initiation. Because EGDT resuscitation end points (eg, Scv o 2 ) can be measured and fl uids administered via preexisting CVCs, we categorized such patients as having EGDT initiated. Importantly, only 13 patients had EGDT initiated through a preexisting CVC. A fourth limitation is the generalizability of our study; other centers may experience signifi cantly different rates of EGDT use. Nevertheless, the barriers that we identifi ed are likely to be experienced at other institutions. Finally, our use of the APACHE II score to assess severity of illness was not used as originally described; 27 nevertheless, its use in the ED has construct and content validity and, given its association with mortality, criterion validity (data not shown).
In conclusion, our study revealed that EGDT was underused and we identifi ed potential barriers to the
